Global Cancer Vaccine Market Research Report 2019

Table of Contents

Executive Summary

1 Cancer Vaccine Market Overview

• 1.1 Product Overview and Scope of Cancer Vaccine
• 1.2 Cancer Vaccine Segment by Type
  • 1.2.1 Global Cancer Vaccine Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Preventive vaccines
  • 1.2.3 Therapeutic vaccines
• 1.3 Cancer Vaccine Segment by Application
  • 1.3.1 Cancer Vaccine Consumption Comparison by Application (2014-2025)
  • 1.3.2 Prostate Cancer
  • 1.3.3 Cervical Cancer
  • 1.3.4 Others
• 1.4 Global Cancer Vaccine Market by Region
  • 1.4.1 Global Cancer Vaccine Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Cancer Vaccine Market Size
  • 1.5.1 Global Cancer Vaccine Revenue (2014-2025)
  • 1.5.2 Global Cancer Vaccine Production (2014-2025)

2 Global Cancer Vaccine Market Competition by Manufacturers

• 2.1 Global Cancer Vaccine Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Cancer Vaccine Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Cancer Vaccine Production Sites, Area Served, Product Types
• 2.5 Cancer Vaccine Market Competitive Situation and Trends
  • 2.5.1 Cancer Vaccine Market Concentration Rate
  • 2.5.2 Cancer Vaccine Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Vaccine Production Market Share by Regions

• 3.1 Global Cancer Vaccine Production Market Share by Regions
• 3.2 Global Cancer Vaccine Revenue Market Share by Regions (2014-2019)
• 3.3 Global Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Cancer Vaccine Production
  • 3.4.1 North America Cancer Vaccine Production Growth Rate (2014-2019)
  • 3.4.2 North America Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Cancer Vaccine Production
  • 3.5.1 Europe Cancer Vaccine Production Growth Rate (2014-2019)
  • 3.5.2 Europe Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Cancer Vaccine Production (2014-2019)
  • 3.6.1 China Cancer Vaccine Production Growth Rate (2014-2019)
  • 3.6.2 China Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Cancer Vaccine Production (2014-2019)
  • 3.7.1 Japan Cancer Vaccine Production Growth Rate (2014-2019)
  • 3.7.2 Japan Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Cancer Vaccine Consumption by Regions

• 4.1 Global Cancer Vaccine Consumption by Regions
• 4.2 North America Cancer Vaccine Consumption (2014-2019)
• 4.3 Europe Cancer Vaccine Consumption (2014-2019)
• 4.4 China Cancer Vaccine Consumption (2014-2019)
• 4.5 Japan Cancer Vaccine Consumption (2014-2019)

5 Global Cancer Vaccine Production, Revenue, Price Trend by Type

• 5.1 Global Cancer Vaccine Production Market Share by Type (2014-2019)
• 5.2 Global Cancer Vaccine Revenue Market Share by Type (2014-2019)
• 5.3 Global Cancer Vaccine Price by Type (2014-2019)
• 5.4 Global Cancer Vaccine Production Growth by Type (2014-2019)

6 Global Cancer Vaccine Market Analysis by Applications

• 6.1 Global Cancer Vaccine Consumption Market Share by Application (2014-2019)
• 6.2 Global Cancer Vaccine Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Cancer Vaccine Business

• 7.1 Dendreon Corporation
  • 7.1.1 Dendreon Corporation Cancer Vaccine Production Sites and Area Served
  • 7.1.2 Cancer Vaccine Product Introduction, Application and Specification
  • 7.1.3 Dendreon Corporation Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 NeoStem Oncology
  • 7.2.1 NeoStem Oncology Cancer Vaccine Production Sites and Area Served
  • 7.2.2 Cancer Vaccine Product Introduction, Application and Specification
  • 7.2.3 NeoStem Oncology Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 ImmunoGen
  • 7.3.1 ImmunoGen Cancer Vaccine Production Sites and Area Served
  • 7.3.2 Cancer Vaccine Product Introduction, Application and Specification
  • 7.3.3 ImmunoGen Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Inovio Pharmaceuticals
  • 7.4.1 Inovio Pharmaceuticals Cancer Vaccine Production Sites and Area Served
  • 7.4.2 Cancer Vaccine Product Introduction, Application and Specification
  • 7.4.3 Inovio Pharmaceuticals Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Novartis
  • 7.5.1 Novartis Cancer Vaccine Production Sites and Area Served
  • 7.5.2 Cancer Vaccine Product Introduction, Application and Specification
  • 7.5.3 Novartis Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served

8 Cancer Vaccine Manufacturing Cost Analysis

• 8.1 Cancer Vaccine Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Cancer Vaccine
• 8.4 Cancer Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Cancer Vaccine Distributors List
• 9.3 Cancer Vaccine Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Cancer Vaccine Market Forecast

• 11.1 Global Cancer Vaccine Production, Revenue Forecast
  • 11.1.1 Global Cancer Vaccine Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Cancer Vaccine Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Cancer Vaccine Price and Trend Forecast (2019-2025)
• 11.2 Global Cancer Vaccine Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Cancer Vaccine Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Cancer Vaccine Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Cancer Vaccine Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Cancer Vaccine Production, Revenue Forecast (2019-2025)
• 11.3 Global Cancer Vaccine Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Cancer Vaccine Consumption Forecast (2019-2025)
  • 11.3.2 Europe Cancer Vaccine Consumption Forecast (2019-2025)
  • 11.3.3 China Cancer Vaccine Consumption Forecast (2019-2025)
  • 11.3.4 Japan Cancer Vaccine Consumption Forecast (2019-2025)
• 11.4 Global Cancer Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Cancer Vaccine Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List